- Home
- IDT vs COLL Comparison
IDT vs COLL Comparison
Compare IDT & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDT
- COLL
- Stock Information
- Founded
- IDT 1990
- COLL 2002
- Country
- IDT United States
- COLL United States
- Employees
- IDT N/A
- COLL N/A
- Industry
- IDT Telecommunications Equipment
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- IDT Telecommunications
- COLL Health Care
- Exchange
- IDT Nasdaq
- COLL Nasdaq
- Market Cap
- IDT 1.2B
- COLL 1.0B
- IPO Year
- IDT 1996
- COLL 2015
- Fundamental
- Price
- IDT $48.64
- COLL $29.13
- Analyst Decision
- IDT
- COLL Strong Buy
- Analyst Count
- IDT 0
- COLL 5
- Target Price
- IDT N/A
- COLL $43.60
- AVG Volume (30 Days)
- IDT 52.0K
- COLL 304.0K
- Earning Date
- IDT 03-05-2025
- COLL 02-27-2025
- Dividend Yield
- IDT 0.41%
- COLL N/A
- EPS Growth
- IDT 101.16
- COLL 757.11
- EPS
- IDT 2.92
- COLL 2.16
- Revenue
- IDT $1,214,139,000.00
- COLL $599,245,000.00
- Revenue This Year
- IDT N/A
- COLL $13.25
- Revenue Next Year
- IDT N/A
- COLL $17.67
- P/E Ratio
- IDT $16.66
- COLL $13.47
- Revenue Growth
- IDT N/A
- COLL 9.62
- 52 Week Low
- IDT $33.84
- COLL $28.39
- 52 Week High
- IDT $58.77
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- IDT 54.22
- COLL 37.61
- Support Level
- IDT $48.45
- COLL $29.39
- Resistance Level
- IDT $49.00
- COLL $30.39
- Average True Range (ATR)
- IDT 0.85
- COLL 1.00
- MACD
- IDT 0.16
- COLL -0.24
- Stochastic Oscillator
- IDT 61.38
- COLL 11.04
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.